![](http://www.biospectrumindia.com/images/content/2010/Oct10/Dr-Shiv-Prakash-Rathnam,--M.jpg) |
![](http://www.biospectrumindia.com/images/content/2010/Oct10/Ms-Monika-Verma-,-CEO-Avanc.jpg) |
![](http://www.biospectrumindia.com/images/content/2010/Oct10/Dr-Ashwini-Nangia,-Professo.jpg) |
Dr Shivprakash
Rathnam,
CEO of Synchron Research Services |
Monika Verma,
CEO of Avancé Phytotherapies
|
Dr Ashwani Nangia,
Professor of Chemistry, University of Hyderabad |
The Indian science team wins the prestigious Indo-UK Biotechnology
Challenge 2010. The event was held at Nottingham University on
September 3, 2010 at the
inaugural function of Academy of Pharmaceutical Sciences Conference, in
the UK. The event was organized jointly by Nottingham Business School,
IIM, Bangalore, and IIT, Kanpur.
The Indian team included Prof Ashwani Nangia from Hyderabad
Central University; Monika Verma, CEO of Avance Phytotherapies,
Ahmedabad; and Dr Shivprakash Rathnam, CEO of Synchron Research
Services, Ahmedabad. The team presented their proposal entitled
‘chalk2salt’, that basically involves converting the physico-chemically
poor drugs into better drugs, with improved properties for better
therapeutic value.
Dr
Russell becomes president of Gene Logic
US-based Gene Logic, an Ocimum Biosolutions company, a leading provider
of genomic solutions with operations in Hyderabad, has announced the
appointment of Dr Norrie J W Russell as its president.
With more than 30 years of experience in drug discovery, Dr Russell has
vast experience in driving innovation in pharmaceutical discovery and
development. He also has experience in leading entrepreneurial
biotechnology companies, raising capital, and developing pioneering new
technologies. Before joining Gene Logic, Dr Russell has held leadership
roles with NovaRx, Invitrogen, Aviva Biosciences, and Lynx Therapeutics.
Prior to moving to the US, Dr Russell had a long career at AstraZeneca,
where he was the global head of Biological Science and Technology, with
responsibility for the application of genomics, genetics and proteomics
to both target discovery and the entire R&D process.
Stempeutics
appoints Dr Majumdar as CSO
Stempeutics Research, a group company of Manipal Education and Medical
Group, has appointed Dr Anish Sen Majumdar as the Chief Scientific
Officer (CSO). Dr Majumdar will lead all the research activities that
are done at Stempeutics. He will also guide the research team in
various experiments conducted, to achieve the desired results.
Dr Majumdar brings with him an in-depth knowledge and rich experience
in the field of stem cell research, from both India and abroad. Prior
to joining Stempeutics, Dr Majumdar worked with the Reliance Life
Sciences Center as vice president. His responsibility there included
developing and directing R&D activities in the areas of both
embryonic and adult stem cells, including mesenchymal stem cells,
ocular stem cells and other somatic cells for therapeutic use in
various types of degenerative diseases.
Dr Poonawalla gets PAHO, PAHEF award
![](http://www.biospectrumindia.com/images/content/2010/Oct10/Crus-S-Poonawalla.jpg)
The Pan
American Health Organization (PAHO) and the Pan American Health and
Education Foundation (PAHEF) have presented Dr Cyrus S Poonawalla,
chairman and managing director of Serum Institute of India, with the
award for ‘Excellence in Inter-American Public Health’, making him the
first Indian to get this prestigious honor.
Dr Poonawalla received this award from Dr Mirta Roses Periago, director
of PAHO for his extraordinary contribution to eliminate rubella and
congenital rubella syndrome in the US.
Prior to this award, Serum Institute and its chairman, Dr Poonawalla
were honored with the Humanitarian Award by Sabin Vaccine Institute,
US, for providing quality vaccines at affordable prices.
Ecron
Acunova gets new CFO
DA Prasanna, founder & chairman of Ecron Acunova (EA), a clinical
research organization (CRO), with presence in Europe and India, has
announced the appointment of Lalit Kanta Mahapatra as chief financial
officer (CFO) of EA.
Mahapatra will be based in Bangalore, and will be responsible for
controllership, financial management and financial integration of
business, across services and geographies.
Reporting to the chairman of the board, he will manage shareholders
expectations, oversee corporate governance and lead the merger and
acquisitions (M&A) activities of the company.
Prior to joining EA, Mahapatra worked with Schneider Electric Company
as head of finance of the global technology center and the project
contracting business. He was part of their global acquisition team, and
was instrumental in acquiring companies in India and Europe.